TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/15/2026
Back to search
Official data from USPTO
PHARM LYSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/17/2026
Trademark type
Combined
Nice classes
1
Filing date
09/19/1996
Registration date
09/02/1997
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/02/2017
Last transaction
06/17/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
04/27/1996
First use in commerce
04/27/1996
Drawing code
5
Owner type
03
Owner location
San Diego, CA, US
Examiner
SNAPP, TINA LOUISE
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PHARMINGEN
Representatives
Keith Toms, Esq. McCarter & English, LLP
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
lysing solutions for use in flow cytometric analyses for scientific or research use
Publications
History of USPTO decisions and trademark events.
27 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/15/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/15/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/15/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/15/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/02/2017
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
10/02/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/02/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/02/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
08/29/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/29/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/17/2007
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/17/2007
PLGL
ASSIGNED TO PARALEGAL
09/10/2007
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
08/24/2007
E89R
TEAS SECTION 8 & 9 RECEIVED
08/24/2007
CFIT
CASE FILE IN TICRS
03/05/2007
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/27/2003
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
08/21/2003
E815
TEAS SECTION 8 & 15 RECEIVED
08/21/2003
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/20/2003
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/1997
PUBO
PUBLISHED FOR OPPOSITION
06/10/1997
NPUB
NOTICE OF PUBLICATION
05/09/1997
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/1997
CNEA
EXAMINER'S AMENDMENT MAILED
04/01/1997
DOCK
ASSIGNED TO EXAMINER
03/18/1997
Continuous trademark protection
Get notified about every new filing that threatens PHARM LYSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.